BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 17323516)

  • 1. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
    Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zanamivir: new indication. Influenza: in children as in adults, symptom relief or vaccination.
    Prescrire Int; 2008 Aug; 17(96):141. PubMed ID: 19480096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influenza].
    Chidiac C
    Rev Prat; 2008 Feb; 58(4):445-53. PubMed ID: 18506987
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
    Uyeki TM
    Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):1-3. PubMed ID: 22233587
    [No Abstract]   [Full Text] [Related]  

  • 20. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.